心房颤动合并高血压的中西医治疗进展
Advances in the Treatment of Atrial Fibrillation Complicated with Hypertension by Traditional Chinese Medicine and Western Medicine
摘要: 近年来心房颤动伴高血压的病人治愈率低、复发率高,治疗此类病人尚无完整的治疗体系、更有效的治疗方案是目前急需攻克的难题。现代医学多在治疗高血压的基础上加用抗凝药物,但长期应用会出现不良反应,导致预后不良。祖国医学对于心房颤动合并高血压的相关研究较少,但在整体观的指导下辨证论治,治疗效果明显。中西医之间各有其优势,亦各有其局限性。现整理分析近几年中西医治疗心房颤动伴高血压的研究进展。
Abstract: In recent years, patients with atrial fibrillation and hypertension have low cure rates, high recurrence rates, and there is no complete treatment system for such patients. A more effective treatment plan is currently an urgent challenge that needs to be overcome. Modern medicine often adds anticoagulant drugs to the treatment of hypertension, but long-term use can lead to adverse reactions and poor prognosis. There is relatively little research on the correlation between atrial fibrillation and hypertension in traditional Chinese medicine, but under the guidance of a holistic approach, the treatment effect is significant through syndrome differentiation and treatment. Both traditional Chinese medicine and Western medicine have their own advantages and limitations. This paper summarizes and analyzes the research progress in the treatment of atrial fibrillation with hypertension using traditional Chinese and Western medicine in recent years.
文章引用:杨胜宏, 刘莉. 心房颤动合并高血压的中西医治疗进展[J]. 临床医学进展, 2024, 14(11): 21-25. https://doi.org/10.12677/acm.2024.14112839

参考文献

[1] 中华医学会心血管病学分会, 中国生物医学工程学会心律分会. 心房颤动诊断和治疗中国指南[J]. 中华心血管病杂志, 2023, 51(6): 572-618.
[2] Chugh, S.S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E.J., et al. (2014) Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study. Circulation, 129, 837-847. [Google Scholar] [CrossRef] [PubMed]
[3] Joglar, J.A., Chung, M.K., Armbruster, A.L., et al. (2024) 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 149, e1-e156.
[4] Kornej, J., Börschel, C.S., Benjamin, E.J. and Schnabel, R.B. (2020) Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights. Circulation Research, 127, 4-20. [Google Scholar] [CrossRef] [PubMed]
[5] Thomas, M.C., Dublin, S., Kaplan, R.C., Glazer, N.L., Lumley, T., Longstreth, W.T., et al. (2008) Blood Pressure Control and Risk of Incident Atrial Fibrillation. American Journal of Hypertension, 21, 1111-1116. [Google Scholar] [CrossRef] [PubMed]
[6] 裴德安, 李莉, 徐志云. 房颤的非离子通道药物治疗: ACEI和ARB [J]. 国际心血管病杂志, 2006, 33(5): 293-296.
[7] Wachtell, K., Lehto, M., Gerdts, E., Olsen, M.H., Hornestam, B., Dahlöf, B., et al. (2005) Angiotensin II Receptor Blockade Reduces New-Onset Atrial Fibrillation and Subsequent Stroke Compared to Atenolol: The Losartan Intervention for End Point Reduction in Hypertension (LIFE) Study. Journal of the American College of Cardiology, 45, 712-719. [Google Scholar] [CrossRef] [PubMed]
[8] Weber, M.A., Julius, S., Kjeldsen, S.E., Brunner, H.R., Ekman, S., Hansson, L., et al. (2004) Blood Pressure Dependent and Independent Effects of Antihypertensive Treatment on Clinical Events in the VALUE Trial. The Lancet, 363, 2049-2051. [Google Scholar] [CrossRef] [PubMed]
[9] Jibrini, M.B., Molnar, J. and Arora, R.R. (2008) Prevention of Atrial Fibrillation by Way of Abrogation of the Renin-Angiotensin System: A Systematic Review and Meta-Analysis. American Journal of Therapeutics, 15, 36-43. [Google Scholar] [CrossRef] [PubMed]
[10] 于泳. 参松养心汤治疗高血压病合并房颤临床观察[J]. 中国中医药现代远程教育, 2022, 20(23): 95-96.
[11] 毕明辉. 定心颗粒对高血压合并阵发性房颤患者清晨血压的影响[J]. 中外医学研究, 2016, 14(34): 110-111.
[12] 高博, 郭飞霞. 稳心颗粒对P波离散度大于40 ms高血压房颤发生的影响[J]. 中医临床研究, 2014, 6(19): 97-98.
[13] 黄金稳, 曹峰, 邓北珍, 等. 缬沙坦联合炙甘草汤治疗高血压合并持续性房颤的疗效[J]. 中国实用神经疾病杂志, 2015, 18(21): 120-121.
[14] 景云佳. 黄芪养心汤联合氯沙坦钾片治疗高血压合并阵发性房颤的临床效果[J]. 心血管病防治知识, 2022, 12(1): 17-19.
[15] 丁力, 周淑妮. 黄芪养心汤联合氯沙坦钾片治疗高血压合并阵发性房颤疗效观察[J]. 现代中西医结合杂志, 2021, 30(27): 3038-3042.
[16] 何欢, 平静, 姜晨辉, 等. 参松养心胶囊联合缬沙坦胶囊对高血压合并持续性房颤患者的临床疗效[J]. 中成药, 2018, 40(11): 2403-2407.
[17] 庹田, 张欣, 程亚玲, 等. 参松养心胶囊联合缬沙坦治疗阵发性房颤对窦性心律维持、左房功能的影响[J]. 中华中医药学刊, 2020, 38(2): 251-254.
[18] 全铁, 范良军, 吕青山, 等. 卡维地洛联合参松养心胶囊对高血压伴阵发性房颤患者P波离散度的影响[J]. 现代医药卫生, 2008, 24(1): 24-26.
[19] 黄铮. 稳心颗粒联合缬沙坦治疗高血压合并阵发性房颤的疗效分析[J]. 实用中西医结合临床, 2021, 21(22): 9-10+98.
[20] 李平平, 乔会侠, 李耀辉. 稳心颗粒联合胺碘酮治疗阵发性房颤气阴两虚证的临床效果[J]. 临床医学研究与实践, 2020, 5(35): 152-154.
[21] 石红梅. 稳心颗粒、美托洛尔对高血压并阵发性房颤患者的疗效观察[J]. 现代预防医学, 2014, 41(21): 4011-4013.
[22] 张志民, 白萍, 林建珍. 稳心颗粒与乙胺碘肤酮联用治疗老年高血压合并阵发性房颤[J]. 中华高血压杂志, 2008, 16(12): 1134-1135.